Why it may matterVerify against the original reporting
Delisting risk typically triggers liquidity concerns, wider spreads, and multiple compression; downside price pressure ahead of a favorable outcome; potential relief if the appeal preserves listing, but uncertainty raises risk premium.
AI summary
What happened, with direct paths to the underlying reporting
Cycurion revealed a Nasdaq delisting determination after CYCU traded below $1 for 31 straight days. The company intends to appeal via a Nasdaq Hearings Panel, which could extend listing if a timely request stays the action. Management says momentum remains strong with a revenue run rate above $28 million, underpinned by backlog and long-term contracts.
Nasdaq issued a delisting determination for CYCU. The stock traded below $1 for 31 consecutive business days.
CYCU did a 1-for-30 reverse split on Oct 27, 2025. Nasdaq denied the 180-day grace period due to the recent split.
CYCU plans a Nasdaq Hearings Panel appeal. A timely request stays suspension pending the panel decision.
Momentum remains strong with revenue run rate over $28M. Backlog and multi-year contracts support growth.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Cycurion has signed a significant multi-year cyber contract valued at $1 million, primarily with a U.S. government agency. This agreement not only boosts immediate revenue but als…
CYCU ranked No. 116 in MSSP Alert's 2025 Top 250 MSSPs list. Q1 2026 run-rate revenue expected at $4.17 million, $16.66 million annualized. Secured $1.1 million contract for data…